Epidemiology of acute myeloid leukemia: Recent progress and enduring challenges
RM Shallis, R Wang, A Davidoff, X Ma, AM Zeidan - Blood reviews, 2019 - Elsevier
Acute myeloid leukemia (AML) is a malignant disorder of the bone marrow which is
characterized by the clonal expansion and differentiation arrest of myeloid progenitor cells …
characterized by the clonal expansion and differentiation arrest of myeloid progenitor cells …
Practice patterns and outcomes for adults with acute myeloid leukemia receiving care in community vs academic settings
AB Halpern, RB Walter - Hematology 2014, the American …, 2020 - ashpublications.org
Consistent with observations in other disease settings, retrospective studies have indicated
that treatment outcomes for adults with acute myeloid leukemia (AML) are better in higher-vs …
that treatment outcomes for adults with acute myeloid leukemia (AML) are better in higher-vs …
Early mortality and overall survival of acute myeloid leukemia based on facility type
Cancer health disparities may exist based on the facility type. We aimed to determine the
association between the academic status of centers and outcomes of patients with acute …
association between the academic status of centers and outcomes of patients with acute …
Association of risk factors, mortality, and care costs of adults with acute myeloid leukemia with admission to the intensive care unit
Importance Adults with acute myeloid leukemia (AML) commonly require support in the
intensive care unit (ICU), but risk factors for admission to the ICU and adverse outcomes …
intensive care unit (ICU), but risk factors for admission to the ICU and adverse outcomes …
Association between treatment facility volume and mortality of patients with multiple myeloma
Purpose To determine the association between the number of patients with multiple
myeloma (MM) treated annually at a treatment facility (volume) and all-cause mortality …
myeloma (MM) treated annually at a treatment facility (volume) and all-cause mortality …
Patterns of care and clinical outcomes with cytarabine-anthracycline induction chemotherapy for AML patients in the United States
AM Zeidan, NA Podoltsev, X Wang, C Zhang… - Blood …, 2020 - ashpublications.org
Cytarabine-anthracycline based intensive induction chemotherapy (IC) remains the
standard of care for remission induction among fit patients with newly diagnosed acute …
standard of care for remission induction among fit patients with newly diagnosed acute …
Early mortality and complications in hospitalized adult Californians with acute myeloid leukaemia
Few studies have evaluated the impact of complications, sociodemographic and clinical
factors on early mortality (death≤ 60 days from diagnosis) in acute myeloid leukaemia …
factors on early mortality (death≤ 60 days from diagnosis) in acute myeloid leukaemia …
Decreased early mortality associated with the treatment of acute myeloid leukemia at National Cancer Institute‐designated cancer centers in California
BACKGROUND To the authors' knowledge, few population‐based studies to date have
evaluated the association between location of care, complications with induction therapy …
evaluated the association between location of care, complications with induction therapy …
Association between treatment at high-volume facilities and improved overall survival in soft tissue sarcomas
Purpose Soft tissue sarcomas (STS) are rare malignancies that require complex
multidisciplinary management. Therefore, facilities with high sarcoma case volume may …
multidisciplinary management. Therefore, facilities with high sarcoma case volume may …
miR-203 inhibits proliferation and self-renewal of leukemia stem cells by targeting survivin and Bmi-1
Drug resistance is one of the leading causes of failed cancer therapy in the treatment of
acute myeloid leukemia. Although the mechanisms of resistance are poorly understood, they …
acute myeloid leukemia. Although the mechanisms of resistance are poorly understood, they …